Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2026 Earnings Call Transcript May 12, 2026
Acurx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.59.
Operator: Greetings, and welcome to the Acurx Pharmaceuticals First Quarter 2026 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. I’d now like to turn the call over to your host, Mr. Rob Shawah, Chief Financial Officer. Please go ahead, sir.
Robert...
